GSK329( GSK-329 | GSK 329 )

Catalog No. M27768 CAS No. 1268490-12-5

GSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	222	Get Quote
10MG	356	Get Quote
25MG	597	Get Quote
50MG	851	Get Quote
100MG	1152	Get Quote
500MG	2313	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

GSK329
Note

Research use only, not for human use.
Brief Description

GSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.
Description

GSK329 is an effective and selective inhibitor of TNNI3 Interacting Kinase (TNNI3K). GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury.
In Vitro

——
In Vivo

——
Synonyms

GSK-329 | GSK 329
Pathway

Others
Target

Other Targets
Recptor

amyloid-β| Caspase
Research Area

——
Indication

——

Chemical Information

CAS Number

1268490-12-5
Formula Weight

472.25
Molecular Formula

C19H14Cl2F3N5O2
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 100 mg/mL (211.75 mM)
SMILES

CNc1cc(Oc2c(Cl)cc(cc2Cl)N(C(N)=O)c2cccc(c2)C(F)(F)F)ncn1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Ju Wang, et al. Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model. Translational Neurodegeneration volume 10, Article number: 12 (2021).

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks